Arcutis Biotherapeutics, Inc. Common Stock — Chart, Price & News (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 3.43 B
Employee 342
Founded 2016
CEO Frank Watanabe
Website www.arcutis.com
Headquarter Delaware, United States
FIGI BBG00QN8K4M4
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

3.43 B Market capitalization

Price to earnings ratio

-223.38

Price to sales ratio

9.82

Dividends per share

—

Dividend yield %

—

Haberler

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham, Arcutis hissesi için hedef fiyatı güçlü satışlarla 36 dolara yükseltti

Needham raises Arcutis stock price target to $36 on strong sales

Güçlü Zoryve satışları sonrası Arcutis hisse hedefi yükseltildi

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis 4Ç 2025 sonuçları: ZORYVE karlılığı artırıyor

Arcutis Q4 2025 slides: ZORYVE drives profitability, revenue beats

Dow Jones Futures Fall Despite Strong Nvidia Earnings After S&P 500 Reclaims Key Level

Arcutis earnings beat by $0.05, revenue topped estimates

Arcutis Biotherapeutics, güçlü sonuçlarla yükseldi